In its March 4, 2013 non-precedential decision in Pettit v. GlaxoSmithKline, LLC, No. 850 EDA 2012, the Pennsylvania Superior Court (applying Ohio law) affirmed an order of Philadelphia Court of Common Pleas Judge Sandra Mazer Moss granting summary judgment to GlaxoSmithKline (GSK) in a case alleging that the GSK-manufactured antidepressant medication Paxil caused birth defects.
Plaintiffs-appellants Mary and Dean Pettit and the estate of their deceased daughter, Danielle Pettit, claimed that Mary having ingested Paxil during the first trimester of her pregnancy was the cause of Danielle’s congenital heart defect, known as hypoplastic left heart syndrome, which led to her death. In their complaint, the Pettits brought negligent failure to warn, negligent misrepresentation, and design defect claims against GSK.
Please see full alert below for more information.
Firefox recommends the PDF Plugin for Mac OS X for viewing PDF documents in your browser.
We can also show you Legal Updates using the Google Viewer; however, you will need to be logged into Google Docs to view them.
Please choose one of the above to proceed!
LOADING PDF: If there are any problems, click here to download the file.